跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,390 条关于
“Microbio (Shanghai)”
全部
5,390
临床试验
4,025
药物
563
机构
201
资讯
601
去年
Breakthrough siRNA Drug SNS812 for COVID-19 Selected for Prestigious ATS 2025 Presentation
2年前
Oneness Biotech's SNS812 Demonstrates Superior Efficacy Against COVID-19 Variants in Phase 2 Trial
去年
MS-20 Shows Remarkable Efficacy as Add-on Therapy for Ulcerative Colitis in Clinical Trial
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
去年
FDA Approves Shanghai Henlius Biotech's Novel ALS Drug HLX99
去年
Henlius Receives Approval for HLX10 in China, Expanding Oncology Portfolio
去年
Roche Invests $300 Million in New Shanghai Biologics Manufacturing Facility
去年
Targeted Therapy Shows Promise in Arteriovenous Malformation Treatment
7个月前
Evogene and Shanghai Lishan Biopharmaceuticals Announce Exclusive Global Licensing Deal for BMC128 Microbiome Cancer Therapy
第 1 页,共 61 页
上一页
下一页